High cholesterol is a major risk factor for cardiovascular disease, including heart attack and stroke. Cholesterol is a waxy substance that the body needs in small amounts, but when levels become too high, it can build up in arteries, forming plaques that narrow and harden blood vessels. Cholesterol-lowering drugs are essential for managing this risk, particularly for people who cannot control their cholesterol through diet and exercise alone. The market for these drugs is one of the largest in pharmaceuticals.

Several classes of cholesterol drugs are available. Statins are the most widely prescribed, working by blocking an enzyme the liver uses to produce cholesterol. They have strong evidence for reducing cardiovascular events. Other classes include ezetimibe, which reduces cholesterol absorption; PCSK9 inhibitors, which are injected and lower LDL cholesterol dramatically; and fibrates, which primarily lower triglycerides. Bile acid sequestrants and niacin are older options. These drugs are used alone or in combination, depending on the patient's needs. Demand is driven by the prevalence of high cholesterol, aging populations, and guidelines recommending treatment for high-risk patients. The Cholesterol Drug Market reflects these trends, with growth supported by these factors.

For patients, cholesterol drugs can significantly reduce the risk of heart attack and stroke when used appropriately. For providers, they are a cornerstone of preventive cardiology. For manufacturers, the market is competitive, with generics dominating statins and innovation focused on new classes. As cardiovascular disease remains a leading cause of death, demand for cholesterol drugs will continue to grow.

People Also Ask

What drugs lower cholesterol?
Statins are the most common, along with ezetimibe, PCSK9 inhibitors, fibrates, bile acid sequestrants, and niacin.

How do statins work?
They block an enzyme the liver uses to produce cholesterol, reducing LDL levels and cardiovascular risk.

Tags: #Cholesterol #HeartHealth #Statins #CardiovascularDisease #Pharmaceuticals #PatientCare